Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Summer 2012 - Vaccines
Download Issue
Share
Up Front
Publisher's Corner
Immunization: An Era of Innovation
By Patrick M. Schmidt
Features
Understanding and Treating IG Side Effects
By
Show No Author
Immunization Innovation: Advancements in Science and Policy Show Potential
By
Hillary Johnson, MHS
Myths and Facts: Lyme Disease
By
Ronale Tucker Rhodes, MS
The ACA’s Impact on Vaccine Administration and Reimbursement
By
Amy Scanlin, MS
Influenza: Past, Present and Future
By
Trudie Mitschang
BioTrends Watch
Washington Report
Federal Court to Reconsider Genetics Patents
New Texas Law for Meningitis Vaccine
States Urged to Prepare for Health Insurance Exchanges
Online Marketplaces Make Medicaid Eligibility Easier
Alzheimer’s Research Receives More Funding
Reimbursement FAQs
Reimbursement FAQs
Industry News
New Vaccine May Prevent Cancer
CSL's rVlla-FP Granted Orphan Drug Designation
Vaccine Update
Smallpox Vaccine Extends Life in Cancer Trial
Slow Release of IG May Delay Alzheimer’s Disease
Positive Results for Phase II Clinical Trial for ITP Patients
HHS Delays ICD-10 Compliance Date
Cangene Recalls HepaGam B Product Lots
BioFocus
Industry Insight
Quadrivalent Flu Vaccines: Four Means More Protection
By Show No Author
Patient Profile
HIV: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Leading the Way in Vaccine Innovation
By Trudie Mitschang
HIV: A Physician’s Perspective
By Trudie Mitschang
BioSources
BioResearch
Immunogenicity and Safety of Quadrivalent Live Attenuated Influenza Vaccine in Children
Intravenous Immunoglobulin Protects Neurons Against Amyloid Beta-Peptide Toxicity: In Vitro and Murine Studies
Biotest’s Investigational 10% Liquid IVIG Assessed in Patients with PIDD